Proteus Genomics

Ben Williams is the CEO of Proteus Genomics. To contact Ben Williams email at [email protected].

The decision makers in Proteus Genomics are Amy Holliman, Ben Williams, Caj Anderson, etc. Click to Find Proteus Genomics decision makers emails.

Proteus Genomics specializes in a wide range of genetic testing services, including pharmacogenomics, which helps determine how a patient's genetics can affect their response to medications. We also provide targeted molecular diagnostics for infectious diseases, women's health, and internal medicine, ensuring that our tests are tailored to meet the specific needs of various clinical settings.

At Proteus Genomics, we adhere to stringent quality control measures and utilize advanced technologies, such as polymerase chain reaction (PCR) and quantitative PCR (qPCR), to ensure the accuracy and reliability of our tests. Our laboratory is equipped with state-of-the-art equipment and staffed by highly trained professionals who follow best practices in molecular diagnostics and microbiology.

Proteus Genomics serves a variety of industries, including healthcare providers, long-term care facilities, assisted living centers, hospitals, and outpatient clinics. Our solutions are designed to support clinicians in improving patient outcomes across diverse fields such as cardiology, urology, wound care, and infectious disease management.

Yes, Proteus Genomics offers specialized testing for antibiotic resistance, which is crucial for guiding effective treatment options for patients with infectious diseases. Our molecular diagnostics can identify specific pathogens and their resistance profiles, allowing healthcare providers to make informed decisions about antibiotic therapies.

To submit a sample for testing at Proteus Genomics, healthcare providers can follow our streamlined process. First, they need to complete a requisition form and ensure that the sample is collected according to our guidelines. Samples can be sent to our laboratory via courier or mail, and results are typically available within a specified turnaround time, which can vary based on the test type.

Proteus Genomics supports clinicians by providing comprehensive molecular diagnostics that enable precise and timely diagnosis of diseases. Our tests are designed to enhance clinical decision-making, reduce trial-and-error in treatment, and ultimately improve patient outcomes. Additionally, we offer educational resources and support to help healthcare providers interpret test results and integrate them into their clinical practice.